Adeno-associated viral vectors deliver gene vaccines
- 30 October 2024
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 281, 117010
Abstract
No abstract availableKeywords
This publication has 205 references indexed in Scilit:
- Regeneration of Capto Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS‐CoV‐2 vaccine candidateBiotechnology Journal, 2022
- Evolving AAV-delivered therapeutics towards ultimate curesJournal of Molecular Medicine, 2021
- Production, Processing, and Characterization of Synthetic AAV Gene Therapy VectorsBiotechnology Journal, 2020
- Autophagy is involved in oral rAAV/Aβ vaccine-induced Aβ clearance in APP/PS1 transgenic miceNeuroscience Bulletin, 2015
- Catalytic Immunoglobulin Gene Delivery in a Mouse Model of Alzheimer’s Disease: Prophylactic and Therapeutic ApplicationsMolecular Neurobiology, 2014
- Specific cellular immune responses in mice immunized with DNA, adeno-associated virus and adenoviral vaccines of Epstein-Barr virus-LMP2 alone or in combinationScience China Life Sciences, 2011
- PEG conjugation moderately protects adeno‐associated viral vectors against antibody neutralizationBiotechnology and Bioengineering, 2005
- Co‐vaccination with adeno‐associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM‐CSF can elicit strong and prolonged neutralizing antibodyInternational Journal of Cancer, 2004
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001
- Development of Oral Vaccines to Stimulate Mucosal and Systemic Immunity: Barriers and Novel StrategiesClinical Immunology and Immunopathology, 1995